Statistical analysis of relative changes of [HbO] during the three experimental tasks in right- and left-handed patients over the right and left SM, PM and DLPF cortices. by Mahdi Mahmoudzadeh (572024)

Phase coherence comparison between sad music condition and SAR. by Ashish Gupta (465372)

Random Forest analysis of cohort 2 sample data using 25 metabolites selected from cohort. by Bryan M. Wittmann (679157)

Phase coherence comparison between SAR condition and baseline resting state. by Ashish Gupta (465372)

Univariate Associations with Number of Acute Exacerbations and COPD-Related Hospitalizations. by Marilyn L. Moy (399580)

Enhanced Bacterial α(2,6)-Sialyltransferase Reaction through an Inhibition of Its Inherent Sialidase Activity by Dephosphorylation of Cytidine-5'-Monophosphate by Ji-Yeon Kang (778073)

Ulcerative Colitis Impairs the Acylethanolamide-Based Anti-Inflammatory System Reversal by 5-Aminosalicylic Acid and Glucocorticoids by Juan Suárez (161921)

Phenotypic characteristics of wild type <i>Mycobacterium tuberculosis</i> H37Rv and Δ<i>dosR</i> under normoxia and hypoxia. by Xin Fang (134979)

Recombinant gp120 proteins cause apoptosis in Primary Human neurons and reduce BDNF levels. by Vasudev R. Rao (625615)

“…Secreted BDNF levels were measured using ELISA and the results were plotted as a percentage of the Control (PBS). Both HIV-1_Bal (US clade-B) and HIV-1_96ZM651 (Southern African clade-C) gp120s resulted in a 40% decrease in secreted BDNF levels at 6 h and a decrease of 60% at 24 h as opposed to HIV-1 IN₁₆₀₅₅ which showed no decrease at 6 h and a 10% decrease at 24 hours compared to Control (PBS). …”

TPMP inhibits mitochondrial respiration and increases glycolytic activity in intact C2C12 cells. by Moustafa Elkalaf (441286)

“…The inhibitory effect following TPMP treatment is demonstrated by a gradual dose-dependent decrease in cellular OCR. Data is expressed as the percentage of basal OCR (OCR%) and is presented as means ±95% CI, n = 4, measured in triplicate. …”

Partial body irradiation and TBI cause significantly different changes in PB cell distributions. by Sarah K. Meadows (89134)

“…(C) TBI causes a modest decrease in PB T cells (Thy 1.2⁺) at 10 Gy; AH, PH and HL irradiation uniformly cause an increase in PB T cells compared to non-irradiated controls, *<i>P</i> = 0.01, **<i>P</i> = 0.04, ^#<i>P</i> = 0.01, ∧<i>P</i> = 0.01, ∧∧<i>P</i> = 0.04, ∧∧∧<i>P</i> = 0.01. …”

Motion sickness and sense of presence in three virtual reality environments developed for manual wheelchair users by Zohreh Salimi (10056224)

Lyn regulated MCP-1 production by activating NF-κB. by Shibichakravarthy Kannan (265789)

Summary of <i>CHL1</i> expression in 11 tumor types as measured with the Clontech Cancer Profiling Arrays I and II. by Vera N. Senchenko (53211)

Comparison of the loss in ME₂₁₅ and change in tryptophan anisotropy in isothermal unfolding kinetics of hVDAC-2 WT. by Svetlana Rajkumar Maurya (516309)

Effects of time on <i>ex vivo</i> spectral imaging. by Torre M. Bydlon (295015)

Impact of inactivation of ependymin in dominant and subdominant zebrafish. by Lynne U. Sneddon (225482)

Mapping the properties of cells in relation to their local neighborhood. by Matthew French (13007466)

“…<b>D:</b> Heightened TBXT and TBX6 CV to the NMP region and decreases into the mesodermal PS. Lines indicate the fit of a non-parametric multiple regression curve and shading indicates 0.05 and 0.95 confidence intervals calculated as (mean ± 1.96 * (<i>σ</i>/(√<i>n</i>)). …”

Summary of study eligibility criteria. by Biban Gill (1473337)

“…Considering the high prevalence of BV among African, Caribbean and Black (ACB) women, we conducted a prospective, randomized, open-label phase 1 clinical trial to determine the feasibility, safety and tolerability of administering low-dose estrogen, probiotics or both in combination to improve vaginal health and decrease HIV-1 susceptibility.…”

Summary of study participation and feasibility. by Biban Gill (1473337)

“…Considering the high prevalence of BV among African, Caribbean and Black (ACB) women, we conducted a prospective, randomized, open-label phase 1 clinical trial to determine the feasibility, safety and tolerability of administering low-dose estrogen, probiotics or both in combination to improve vaginal health and decrease HIV-1 susceptibility.…”